Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study
Contributeurs/tricesChalandon, Yves; Mamez, Anne-Claire; Giannotti, Federica; Beauverd, Yan; Dantin, Carole Alice; Mahne, Elif; Mappoura, Maria; Bernard, Fanette; De Ramon Ortiz, Carmen Julia; Stephan, Caroline; Morin, Sarah; Ansari Djaberi, Marc Georges; Simonetta, Federico; Masouridi Levrat, Stavroula
Publié dansTransplantation and cellular therapy, vol. 28, no. 11, p. 765.e1-765.e9
Date de publication2022-11
Date de mise en ligne2022-08-08
Résumé
Mots-clés
- Allogeneic stem cell transplantation
- Defibrotide
- Prophylaxis
- Veno-occlusive disease
- Humans
- Hepatic Veno-Occlusive Disease / drug therapy
- Retrospective Studies
- Prospective Studies
- Graft vs Host Disease / prevention & control
- Hematopoietic Stem Cell Transplantation / adverse effects
Citation (format ISO)
CHALANDON, Yves et al. Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study. In: Transplantation and cellular therapy, 2022, vol. 28, n° 11, p. 765.e1–765.e9. doi: 10.1016/j.jtct.2022.08.003
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:174536
- DOI : 10.1016/j.jtct.2022.08.003
- PMID : 35953029
ISSN du journal2666-6367